These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 2085427)

  • 61. Hypersensitivity reactions to synthetic haemodialysis membranes.
    Sánchez-Villanueva RJ; González E; Quirce S; Díaz R; Alvarez L; Menéndez D; Rodríguez-Gayo L; Bajo MA; Selgas R
    Nefrologia; 2014; 34(4):520-5. PubMed ID: 25036066
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cardiopulmonary events during hemodialysis: effects of dialysis membranes and dialysate buffers.
    Munger MA; Ateshkadi A; Cheung AK; Flaharty KK; Stoddard GJ; Marshall EH
    Am J Kidney Dis; 2000 Jul; 36(1):130-9. PubMed ID: 10873882
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Biocompatibility of hemodialysis membranes: evaluation in an ovine model.
    Burhop KE; Johnson RJ; Simpson J; Chenoweth DE; Borgia J
    J Lab Clin Med; 1993 Feb; 121(2):276-93. PubMed ID: 8433041
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Is platelet-activating factor produced during hemodialysis with AN-69 polyacrylonitrile membrane?
    Iatrou C; Afentakis N; Nomikos T; Dinas C; Stavropoulos-Giokas C; Antonopoulou S
    Nephron; 2002 May; 91(1):86-93. PubMed ID: 12021524
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Filtration fluid for hemodialysis treatment.
    Ikonomov V; Haase G; Stefanidis I; Melzer H; Mann H
    Int J Artif Organs; 2002 May; 25(5):379-85. PubMed ID: 12074334
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Production and kinetics of interleukin-1 in hemodialysis. In vivo and in vitro study.
    Donati D; Degiannis D; Homer L; Raska K; Raskova J
    Am J Nephrol; 1991; 11(6):451-8. PubMed ID: 1819211
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Adverse reactions to polysulphone membrane dialyzers durind hemodialysis].
    Arenas MD; Gil MT; Carretón MA; Moledous A; Albiach B
    Nefrologia; 2007; 27(5):638-42. PubMed ID: 18045043
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The role of plasma coating on the permeation of cytokine-inducing substances through dialyser membranes.
    Lonnemann G; Schindler R; Lufft V; Mahiout A; Shaldon S; Koch KM
    Nephrol Dial Transplant; 1995; 10(2):207-11. PubMed ID: 7753454
    [TBL] [Abstract][Full Text] [Related]  

  • 69. C-reactive protein in patients on chronic hemodialysis with different techniques and different membranes.
    Panichi V; Rizza GM; Taccola D; Paoletti S; Mantuano E; Migliori M; Frangioni S; Filippi C; Carpi A
    Biomed Pharmacother; 2006 Jan; 60(1):14-7. PubMed ID: 16330177
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Permeability of cellulosic and non-cellulosic membranes to endotoxin subunits and cytokine production during in-vitro haemodialysis.
    Ureña P; Herbelin A; Zingraff J; Lair M; Man NK; Descamps-Latscha B; Drüeke T
    Nephrol Dial Transplant; 1992; 7(1):16-28. PubMed ID: 1316577
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Vancomycin elimination during high-flux hemodialysis: kinetic model and comparison of four membranes.
    DeSoi CA; Sahm DF; Umans JG
    Am J Kidney Dis; 1992 Oct; 20(4):354-60. PubMed ID: 1415203
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Middle molecule removal in low-flux polysulfone dialyzers: impact of flows and surface area on whole-body and dialyzer clearances.
    Eloot S; de Vos JY; de Vos F; Hombrouckx R; Verdonck P
    Hemodial Int; 2005 Oct; 9(4):399-408. PubMed ID: 16219061
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Ultrafiltration using the polysulfone membrane to reduce the cytokine-inducing activity of contaminated dialysate.
    Lonnemann G; Schindler R
    Clin Nephrol; 1994 Jul; 42 Suppl 1():S37-43. PubMed ID: 7923982
    [No Abstract]   [Full Text] [Related]  

  • 74. New generation ceramic membranes have the potential of removing endotoxins from dialysis water and dialysate.
    Czermak P; Ebrahimi M; Catapano G
    Int J Artif Organs; 2005 Jul; 28(7):694-700. PubMed ID: 16049903
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Kinin kinetics during different dialysis protocols with AN69 dialyser in ACEI-treated patients.
    Van der Niepen P; Sennesael JJ; Verbeelen DL
    Nephrol Dial Transplant; 1995; 10(9):1689-95. PubMed ID: 8559490
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Differences in the permeability of high-flux dialyzer membranes for bacterial pyrogens.
    Schindler R; Christ-Kohlrausch F; Frei U; Shaldon S
    Clin Nephrol; 2003 Jun; 59(6):447-54. PubMed ID: 12834177
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evolution of serum prealbumin following hemodialysis: effect of different dialysis membranes.
    Docci D; Bilancioni R; Pistocchi E; Baldrati L; Capponcini C; Delvecchio C; Feletti C
    Nephron; 1992; 62(2):145-9. PubMed ID: 1436305
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Mechanisms Involved in Hypersensitivity Reactions to Polysulfone Hemodialysis Membranes.
    Rodríguez-Sanz A; Sánchez-Villanueva R; Domínguez-Ortega J; Fiandor AM; Ruiz MP; Trocoli F; Díaz-Tejeiro R; Cadenillas C; González E; Martínez V; López-Trascasa M; Quirce S; Selgas R; Bellón T
    Artif Organs; 2017 Nov; 41(11):E285-E295. PubMed ID: 28722144
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effects of a reduced inner diameter of hollow fibers in hemodialyzers.
    Ronco C; Brendolan A; Lupi A; Metry G; Levin NW
    Kidney Int; 2000 Aug; 58(2):809-17. PubMed ID: 10916106
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Potential of dual-skinned, high-flux membranes to reduce backtransport in hemodialysis.
    Soltys PJ; Zydney A; Leypoldt JK; Henderson LW; Ofsthun NJ
    Kidney Int; 2000 Aug; 58(2):818-28. PubMed ID: 10916107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.